GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » EV-to-EBIT

Stryker (Stryker) EV-to-EBIT

: 35.86 (As of Today)
View and export this data going back to 1988. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Stryker's Enterprise Value is $140,082 Mil. Stryker's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $3,906 Mil. Therefore, Stryker's EV-to-EBIT for today is 35.86.

The historical rank and industry rank for Stryker's EV-to-EBIT or its related term are showing as below:

SYK' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.28   Med: 26.99   Max: 54.28
Current: 35.86

During the past 13 years, the highest EV-to-EBIT of Stryker was 54.28. The lowest was 12.28. And the median was 26.99.

SYK's EV-to-EBIT is ranked worse than
75.38% of 463 companies
in the Medical Devices & Instruments industry
Industry Median: 19.25 vs SYK: 35.86

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Stryker's Enterprise Value for the quarter that ended in Dec. 2023 was $123,767 Mil. Stryker's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $3,906 Mil. Stryker's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.16%.


Stryker EV-to-EBIT Historical Data

The historical data trend for Stryker's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.36 46.04 41.09 34.09 31.69

Stryker Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.09 36.09 36.30 31.44 31.69

Competitive Comparison

For the Medical Devices subindustry, Stryker's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker EV-to-EBIT Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Stryker's EV-to-EBIT falls into.



Stryker EV-to-EBIT Calculation

Stryker's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=140081.705/3906
=35.86

Stryker's current Enterprise Value is $140,082 Mil.
Stryker's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,906 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker  (NYSE:SYK) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Stryker's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=3906/123766.746
=3.16 %

Stryker's Enterprise Value for the quarter that ended in Dec. 2023 was $123,767 Mil.
Stryker's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,906 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Stryker's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (Stryker) Business Description

Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
Srikant Datar director ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
Berry William E Jr officer: Vice President, Controller 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo officer: Group Pres., Neurotech & Spine STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston director 2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell officer: Group President 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen officer: VP 2825 AIRVIEW BLVD., KALAMAZOO MI 49002

Stryker (Stryker) Headlines

From GuruFocus

Stryker Corp To Host Investor Day Transcript

By GuruFocus Research 01-23-2024

Q3 2020 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Stryker Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024